Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Equity Average (2021 - 2025)

Incannex Healthcare's Equity Average history spans 3 years, with the latest figure at $75.2 million for Q4 2025.

  • On a quarterly basis, Equity Average rose 1889.87% to $75.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $75.2 million, a 1889.87% increase, with the full-year FY2025 number at $12.3 million, changed N/A from a year prior.
  • Equity Average hit $75.2 million in Q4 2025 for Incannex Healthcare, up from $45.2 million in the prior quarter.
  • Over the last five years, Equity Average for IXHL hit a ceiling of $75.2 million in Q4 2025 and a floor of $3.8 million in Q4 2024.
  • Historically, Equity Average has averaged $20.8 million across 3 years, with a median of $12.7 million in 2024.
  • Biggest five-year swings in Equity Average: tumbled 80.45% in 2024 and later skyrocketed 1889.87% in 2025.
  • Tracing IXHL's Equity Average over 3 years: stood at $19.3 million in 2023, then tumbled by 80.45% to $3.8 million in 2024, then skyrocketed by 1889.87% to $75.2 million in 2025.
  • Business Quant data shows Equity Average for IXHL at $75.2 million in Q4 2025, $45.2 million in Q3 2025, and $10.4 million in Q2 2025.